Advances in clinical chemistry

733 papers and 22.0k indexed citations i.

About

The 733 papers published in Advances in clinical chemistry in the last decades have received a total of 22.0k indexed citations. Papers published in Advances in clinical chemistry usually cover Molecular Biology (261 papers), Physiology (100 papers) and Cancer Research (88 papers) specifically the topics of Metabolism and Genetic Disorders (37 papers), Metabolomics and Mass Spectrometry Studies (31 papers) and MicroRNA in disease regulation (27 papers). The most active scholars publishing in Advances in clinical chemistry are Giuseppe Lippi, Giuseppe Banfi, Gianfranco Cervellin, Giovanni Lombardi and Mario Plebani.

In The Last Decade

Fields of papers published in Advances in clinical chemistry

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Advances in clinical chemistry. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Advances in clinical chemistry

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Advances in clinical chemistry. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Advances in clinical chemistry with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025